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Abstract
Persistence of a reservoir of latently infected memory T cells provides a barrier to HIV eradication in treated patients. Several
reports have implicated the involvement of SWI/SNF chromatin remodeling complexes in restricting early steps in HIV
infection, in coupling the processes of integration and remodeling, and in promoter/LTR transcription activation and
repression. However, the mechanism behind the seemingly contradictory involvement of SWI/SNF in the HIV life cycle
remains unclear. Here we addressed the role of SWI/SNF in regulation of the latent HIV LTR before and after transcriptional
activation. We determined the predicted nucleosome affinity of the LTR sequence and found a striking reverse correlation
when compared to the strictly positioned in vivo LTR nucleosomal structure; sequences encompassing the DNase
hypersensitive regions displayed the highest nucleosome affinity, while the strictly positioned nucleosomes displayed lower
affinity for nucleosome formation. To examine the mechanism behind this reverse correlation, we used a combinatorial
approach to determine DNA accessibility, histone occupancy, and the unique recruitment and requirement of BAF and
PBAF, two functionally distinct subclasses of SWI/SNF at the LTR of HIV-infected cells before and after activation. We find
that establishment and maintenance of HIV latency requires BAF, which removes a preferred nucleosome from DHS1 to
position the repressive nucleosome-1 over energetically sub-optimal sequences. Depletion of BAF resulted in de-repression
of HIV latency concomitant with a dramatic alteration in the LTR nucleosome profile as determined by high resolution
MNase nucleosomal mapping. Upon activation, BAF was lost from the HIV promoter, while PBAF was selectively recruited by
acetylated Tat to facilitate LTR transcription. Thus BAF and PBAF, recruited during different stages of the HIV life cycle,
display opposing function on the HIV promoter. Our data point to the ATP-dependent BRG1 component of BAF as a
putative therapeutic target to deplete the latent reservoir in patients.
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Introduction
After host cell infection and entry into the nucleus, the Human
immunodeficiency virus (HIV-1) DNA integrates into the host
genome as a chromatin template. Through unclear mechanisms, a
very small percentage of infected T cells become latent. Despite
the successes of modern Highly Active Anti-Retroviral Therapy
(HAART) in suppressing viral replication, the presence of latently
infected resting memory CD4+T cells provides the main
impediment to curing HIV [1–3]. Infected patients must receive
continuous HAART, as treatment interruption results in rapid
rebound of viremia [4]. Latent HIV-1 infected resting memory
CD4+T cells harbor replication competent virus, which is blocked
at the level of transcription.
Transcription of the HIV-1 virus is driven by the LTR and is
restricted in vivo. Regardless of the position of virus integration in
the host genome, within the 59LTR, the nucleosomes are strictly
deposited at specific positions [5–7]. Chromatin organization of
the HIV-1 provirus characterized by nuclease digestion of intact
nuclei of infected cells under basal conditions demonstrates the
presence of at least three precisely positioned nucleosomes, nuc-0,
nuc-1, and nuc-2 and their intervening nucleosome-free regions
[5,6]. In particular, nuc-1, the nucleosome positioned immediately
downstream of the transcription start site, is repressive to
transcription and is surrounded by two large domains of
nucleosome-free DNA. Following activation, nuc-1 becomes
rapidly and specifically disrupted [5,8].
To overcome nucleosome mediated repression, the cell uses at
least two mechanisms to increase the accessibility of DNA
sequences embedded within nucleosomes. The first is through
the action of enzymatic complexes which covalently modify
histones. Histone modifying complexes are thought to regulate
transcription at the HIV LTR. For example, HDAC1 is recruited
to and represses transcription at the LTR [9–11]. Following
activation, histone acetylation surrounding nuc-1 has been
demonstrated to increase significantly, concomitant with removal
of HDAC [7,10,12,13]. Many histone-modifying enzymes have
been shown to be recruited to the LTR by the HIV transactivator
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binding sites are present on the LTR. Tat itself is subject to distinct
modifications by various factors (including p300/CBP, PCAF,
hGCN5, SIRT1, PRMT5, SETDB1, SETDB2, SET7/9 KMT7)
[14,15], a mechanism to modulate its interaction with the many
cofactors Tat recruits to the LTR.
The second mechanism for altering DNA accessibility within
repressive nucleosomes is via enzymatic complexes, which use
energy from ATP hydrolysis to alter the structure of chromatin
[16,17]. One family of remodeling complexes, SWI/SNF, contains
either Brahma (BRM) or the closely related BRG1 as its catalytic
subunit and shares most common subunits [16–22]. At least two
biochemically distinct SWI/SNF complexes with different func-
tions have been described and are called BAF and PBAF. The
PBAF complex contains either BRG1 or BRM together with the
PBAF-specific subunits BAF180, BAF200, SAYP, and Brd7, but
lacks BAF250 [23–27]. The BAF complex contains either BRG1
or BRM together with the BAF-specific subunit BAF250, but lacks
PBAF-specific subunits (Figure 1A) [28,29]. The presence of
distinct isoforms of subunits such as BAF60 also increases the
number of possible complexes [16,17]. BAF- or PBAF-specific
subunits have been implicated in transcriptional activation by
selective nuclear hormone receptors [24,28,30,31], in distinct roles
in cell cycle control and mitosis [29,32], and the expression of
interferon-responsive genes [26]. OSA, the Drosophila BAF-
specific subunit, is required for repression of Wingless target genes
[33]. BAF and PBAF subunit-specific polytene staining of
Drosophila salivary glands indicates that the complexes are
recruited to distinct targets [34]. These and other studies suggest
that BAF and PBAF complexes perform distinct functions in
transcription regulation.
In the immediate-early phase of HIV infection, cellular
transcription factors activate transcription from the viral promoter
in the 59LTR, leading to accumulation of viral Tat protein, a
potent transactivator. Tat binds TAR, an RNA stem-loop in the
nascent viral RNA, and recruits a positive transcription elongation
factor complex (pTEFb) containing CDK9 and cyclinT1. This
recruitment leads to the phosphorylation of the carboxyl-terminal
domain of RNA PolII and increased transcriptional elongation. In
turn, more efficient transcription of the HIV genome, including
Tat, generates a Tat-dependent positive feedback loop [15].
Tat also leads to the remodeling of nuc-1 [5,35], the
nucleosome positioned immediately downstream of the transcrip-
tion start site. We and others have reported that Tat recruits the
SWI/SNF chromatin-remodeling complex to the HIV LTR to
activate transcription [36–39]. SWI/SNF was also shown to
promote HIV transcription elongation via a Tat-independent
mechanism [40]. INI-1 (hSNF5), a core subunit to all SWI/SNF
complexes, was first identified because of its interaction with HIV
IN [41]. In addition to its direct involvement in Tat-mediated
LTR activation [38,39], INI-1 was shown to restrict early steps of
HIV infection [42] and to repress basal LTR activity [43].
Recently, the interaction between the HIV IN and SWI/SNF was
suggested to functionally couple the processes of integration and
remodeling necessary for integration into stable nucleosomes [44].
However, despite these studies on regulation of the HIV life cycle
by SWI/SNF, the mechanism behind the seemingly contradictory
involvement of SWI/SNF in regulating various stages of the HIV
life cycle (i.e. integration, transcription activation, as well as
repression) is not understood. Here we examined the mechanistic
role played by SWI/SNF in the establishment and maintenance of
HIV latency and its re-activation.
Results
The SWI/SNF and MI2 Family of ATP-Dependent
Chromatin Remodeling Enzymes Are Involved in LTR
Repression
We and other laboratories previously reported the requirement
of SWI/SNF chromatin remodeling complexes on activation of
HIV-1 LTR [36–40]. To investigate further the role of ATP-
dependent remodelers on LTR regulation, we examined the effect
of cellular ATP depletion by sodium azide (NaN3) on LTR activity
and chromatin remodeling. We treated a Jurkat cell line
containing an integrated LTR-GFP virus (Figure S1B and S1C)
[45] as well as J-Lat A2 [46], containing an integrated latent LTR-
Tat-IRES-GFP virus (Figure S1D and S1E) with increasing
concentrations of NaN3. Surprisingly, in the absence of Tat
expression, addition of NaN3 was associated with derepression of
basal HIV promoter activity (Figure S1C and S1E). To determine
whether this derepression was associated with chromatin remod-
eling of the HIV promoter, we used a restriction enzyme
accessibility assay coupled to indirect end-labeling, as described
[5]. In this assay, nuc-1 remodeling leads to increased accessibility
of the restriction enzyme AflII to its recognition site, generating a
novel restriction fragment (Figure S1A). Nuc-1 remodeling was
assayed in untreated cells, in cells treated with PMA as a positive
control, and in cells treated with NaN3 (Figure S1B and S1D). We
observed nuc-1 remodeling in response to NaN3 at the same
concentrations that induced HIV promoter derepression (Figure
S1C and S1E). Thus, with the caveat that toxicity resulting from
cellular ATP depletion by NaN3 may be accompanied by non-
specific effects, these observations suggested that ATP dependent
chromatin remodeling activity is required to suppress basal
promoter activity.
To determine which family of ATP-dependent chromatin
remodeling enzymes may be involved in LTR repression, we
used siRNAs to deplete the expression of the catalytic subunit of
each class of mammalian remodelers. There are four major
families of remodelers, each named after their central ATPase:
Author Summary
Despite the effectiveness of antiretroviral medication, the
HIV virus persists in resting memory T cells of infected
patients in a latent state, providing the main impediment
to eradication of the virus. In this article, we examined the
molecular mechanism responsible for the establishment
and maintenance of HIV latency and its re-activation, and
uncovered the role played in this process by the SWI/SNF
class of chromatin remodeling complexes, which use
energy from ATP to alter the structure of chromatin. We
show that two distinct sub-classes of SWI/SNF, BAF and
PBAF, play functionally opposing roles in distinct steps of
the HIV promoter (or long terminal repeat, LTR) transcrip-
tion cycle. The PBAF complex augments transcription of
the LTR by the viral transactivator Tat. In contrast, the
distinct BAF complex generates a chromatin structure at
the LTR that is energetically unfavorable with respect to
the intrinsic histone-DNA sequence preferences. Specifi-
cally, we find that BAF positions a repressive nucleosome
immediately downstream of the HIV transcription start site,
abrogating transcription, and in this way contributes to
the establishment and maintenance of HIV latency. Our
data describe a novel molecular mechanism for the
establishment and maintenance of HIV latency, and we
identify the catalytic subunit of BAF, the enzyme BRG1, as
a putative molecular target to deplete the latent reservoir
in infected patients.
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PLoS Biology | www.plosbiology.org 2 November 2011 | Volume 9 | Issue 11 | e1001206Figure 1. SWI/SNF and MI2 family of ATP-dependent chromatin remodeling enzymes are involved in LTR repression. (A) Four distinct
classes of mammalian ATP-dependent chromatin remodeling complexes distinguished by their catalytic subunits, BRG-1/BRM (SWI/SNF), ISWI, INO80,
or CHD3/4 (MI2). (B) RNAi depletion of ATPase subunit of each class of ATP-dependent chromatin remodeling complexes as indicated in J-Lat A2 cells
containing an integrated latent LTR-Tat-IRES-GFP virus. Cells were nucleofected with control siRNA or siRNAs targeting INO80, CHD3, ISWI, BRG1, and
BRM as indicated. GFP expression was monitored by FACS at indicated times post-transfection and is presented as % GFP-positive cells. (C) Western
blot analysis to demonstrate depletion of individual ATPase subunits as indicated 3 and 6 d after transfection of siRNAs. RT-PCR analysis indicated
stable depletion of INO80 mRNA up to 8 d after siRNA transfection. Error bars represent the SEM of three independent experiments. * p,0.05,
** p,0.01.
doi:10.1371/journal.pbio.1001206.g001
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(Figure 1A) [16,17]. Specific siRNAs directed against each
catalytic subunit were transfected via nucleofection into J-Lat A2
cells (Figure 1B) leading to the efficient depletion of each factor as
shown by Western blot analysis for CHD3, ISWI, BRG1, and
BRM and by RT-PCR for INO80 (Figure 1C). Depletion of
CHD3 resulted in derepression of latent HIV LTR activity as
measured by an increase in GFP expression (Figure 1B). In
support of this observation, the CHD3 containing NuRD complex
as well as the methyl CpG binding protein MBD2, which is
another component of the NuRD complex, were shown to be
involved in LTR repression [47,48]. The related CHD1 protein
was also shown to repress the HIV LTR [49]. siRNA nucleofec-
tion had no non-specific effect on LTR-driven GFP expression.
While depletion of INO80, ISWI, or BRM had no affect on LTR
activity, we found robust de-repression of latent LTR upon BRG1
depletion. This suggested that a BRG1 containing SWI/SNF
complex represses basal HIV promoter activity and may be
required for maintaining latency.
Repression of Basal HIV Promoter Activity by the BAF
Complex
The HIV transactivator Tat recruits the SWI/SNF ATP-
dependent chromatin-remodeling complex to the LTR to activate
transcription [36–39]. The observation that the HIV preintegra-
tion complex interacts with the core SWI/SNF subunit INI-1/
hSNF5 in the cytoplasm before integration [41,44,50] suggested
that the SWI/SNF complex might also regulate the activity of the
HIV LTR immediately after integration, before Tat accumulation.
In support of this notion, INI-1 has been implicated in both LTR
activation and repression [38,39,43].
To examine this possibility, and determine which of the
compositionally distinct SWI/SNF complexes, BAF or PBAF
(Figure 2A), may be responsible for repressing HIV LTR, we used
siRNAs to deplete the expression of selected subunits, in two clonal
Jurkat cell lines (clones D and E) that contain single integrations of
the minimal HIV genome, LTR-GFP virus lacking Tat, and
expressing low levels of GFP (Figure 2B and 2C). To dissect the
requirements of distinct BAF/PBAF complexes in basal LTR-
driven, Tat-independent transcription, siRNAs directed against
the core subunits BRG1, BRM, INI-1, the PBAF-specific subunit
BAF180, and the BAF-specific subunit BAF250a were transfected
via nucleofection leading to the efficient depletion of each factor as
shown for Jurkat clone D by Western blot analysis (Figure 2D). We
used BAF180 depletion to examine the effect of PBAF on LTR-
driven transcription as depletion of the PBAF-specific BAF200 was
previously reported to result in disruption of the complex [26]. To
ensure that the stability of the complex is not compromised when
one component of the complex is depleted by siRNA, we
examined the protein levels of the other SWI/SNF subunit by
Western blot analysis after depletion of each subunit. SWI/SNF
subunit protein levels were unaffected by siRNA depletion of
specific subunits (Figure S2). HIV promoter activity was
monitored using flow cytometry by measuring changes in Mean
Fluorescent Intensity (MFI) of the low basal GFP fluorescence in
Jurkat clones D and E for 2 wk after siRNA depletion of SWI/
SNF subunits (Figure 2B and 2C). Depletion of BRG1, INI-1, and
the BAF-specific BAF250a resulted in derepression of HIV
promoter activity as measured by an increase in GFP expression
monitored over 14 d. In contrast, depletion of BRM or the PBAF-
specific BAF180 did not affect LTR activity (Figures 2B, 2C, and
1B). Derepression of HIV LTR activity peaked at approximately
8 d followed by de novo repression. LTR derepression was tightly
correlated with depletion of SWI/SNF subunits as shown by
Western blot analysis (Figure 2D). Derepression of basal HIV
promoter activity in response to BAF250a depletion suggested that
the BAF complex, which is defined by the unique BAF250 subunit,
is required for repression of basal LTR activity. In agreement with
this model, depletion of BAF180, unique to PBAF, had no effect
on basal repressed HIV promoter activity. Identical results
observed with both Jurkat clones containing integrated HIV
LTR-GFP demonstrated that this effect occurs independent of the
two distinct integration sites.
Latent HIV Is Derepressed Upon BAF Depletion
Suppression by the BAF complex was also observed during a
latent HIV infection. SWI/SNF subunits were depleted as
described above by siRNA in two Jurkat clonal cell lines, J-Lat
A2 and J-Lat 11.1, which harbor latent HIV [46]. J-Lat A2
contains an integrated latent LTR-Tat-IRES-GFP virus
(Figure 3A), and J-Lat 11.1 contains a full-length HIV-1 genome
expressing GFP in place of Nef (Figure 3B). J-Lat cells are not
transcribing, and are therefore GFP negative in the latent state.
Because of the absence of Tat expression, this system is ideal to
examine the role of chromatin modulators in derepression of latent
LTR, which leads to an increase in the percentage of LTR-driven
GFP expressing cells. We depleted core and BAF/PBAF-specific
SWI/SNF subunits from J-Lat cells by siRNA transfection. To
ensure that the BRG-1 complex remains intact following depletion
of BAF- or PBAF-specific subunits, we immunoprecipitated BRG-
1 from J-Lat A2 cell lysates, which were either undepleted or
depleted of BAF250 or BAF180 and probed for the presence of
BAF/PBAF subunits by Western blot analysis (Figure 3C).
Depletion of BAF180 or BAF250 did not affect the binding of
the other core or specific SWI/SNF subunits to the BRG-1
immunoprecipitated complexes, supporting the notion that there is
no cross-talk between these distinct SWI/SNF complexes. In both
J-Lat cell lines, depletion of BRG1, INI-1, or the BAF-specific
subunit BAF250a resulted in derepression of HIV expression, as
demonstrated by an increase in percent GFP-positive cells. GFP
expression peaked 6–10 d after siRNA nucleofection (Figure 3A
and 3B) and inversely correlated with expression of BRG1, INI-1,
and BAF250a (unpublished data). To address the perceived lag
between factor depletion and GFP detection by FACS analysis,
which peaked at 6–10 d following siRNA transfection, we
performed RT-qPCR time-course analysis of GFP mRNA
expression in J-Lat A2 cells after siRNA depletion of BAF250
and BRG-1 (Figure S3A). GFP mRNA was significantly induced
as early as 2 d post-siRNA transfection, at the same time point in
which significant protein depletion is achieved, and peaked at 4–
5 d following siRNA transfection. Thus the delay in GFP detection
by FACS appears to be a matter of accumulation of GFP protein
over background levels. We also examined the effect of depletion
of BAF250b, a BAF-specific complex component also expressed in
Jurkat cells, which is functionally and biochemically distinct from
the BAF250a complex [51], on LTR regulation in J-Lat A2 cells
(Figure S3B). While depletion of BAF250a and BRG-1 caused
robust expression of GFP mRNA, depletion of BAF250b had no
effect on LTR transcription. These results demonstrated that the
BAF250a-containing BAF complex is specifically required for
maintenance of repression of latent HIV.
K50,51 Acetylated Tat Coimmunoprecipitates with and
Requires PBAF for Transactivation of HIV Promoter
We and others reported that a SWI/SNF complex associates
with Tat to activate the HIV promoter [36–39]. A recent study
found that depletion of neither the PBAF-specific BAF180 nor
BAF250a had any effect on Tat-mediated LTR activation, while
Repressive HIV LTR Nucleosome Positioning by BAF
PLoS Biology | www.plosbiology.org 4 November 2011 | Volume 9 | Issue 11 | e1001206Figure 2. The BAF complex represses basal transcription at the HIV promoter. (A) Table of subunit composition of the two distinct SWI/SNF
complexes, BAF and PBAF, in mammals. (B) GFP expression was monitored by flow cytometry at indicated times after siRNA transfection to measure
HIV promoter activity. Results are presented as MFI for cells treated with a control siRNA or siRNAs specific for SWI/SNF subunits. (C) Same
experiments as shown in (B) for clone D, with clone E, another Jurkat cell line containing an integrated LTR-GFP virus. Error bars represent the SEM of
five independent experiments. * p,0.05. (D) Jurkat cells containing an integrated LTR-GFP virus (clone D) were transfected with control siRNA or
siRNAs targeting various SWI/SNF complex subunits as indicated. Western blot analysis shows expression of each SWI/SNF subunit after its specific
depletion 0, 2, 4, 6, 7, 8, 10, and 14 d after siRNA transfection with each specific antibody and b-actin loading control as indicated.
doi:10.1371/journal.pbio.1001206.g002
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activation of the LTR [52]. We and other laboratories have found
synergism between the acetyltransferase p300 and SWI/SNF in
LTR activation. This activation was found to be dependent on Tat
acetylation [36,38]. Our novel data indicating derepression of
LTR transcription in response to depletion of BAF-specific
subunits suggested that the BAF complex is recruited to the
HIV promoter independently of Tat. We therefore sought to
determine which SWI/SNF complex, PBAF or BAF, is specifically
recruited and required by Tat to activate transcription, and
whether Tat acetylation is necessary for this interaction. We
performed immunoprecipitation experiments in the J-Lat A2 cells,
which express no Tat under basal conditions and epitope-tagged
Tat (Tat-FLAG) after reactivation of HIV by PMA (Figure 4A).
Using this system we have shown previously that Tat coimmuno-
precipitated with INI-1, BRG1, and b-actin, three core subunits
shared between BAF and PBAF complexes [38]. Importantly, Tat
co-immunoprecipitated with BAF180, but not with BAF250a or
the unrelated protein kinase D (Figure 4A). Thus, Tat interacts
specifically with the BAF180-containing PBAF complex.
To determine whether the interaction of Tat with PBAF is
modulated by acetylation, we cotransfected 293T cells with wild-
type or K50R/K51R mutant Tat in the presence or absence of a
p300 expression vector (Figure 4B). To prevent Tat deacetylation,
cells were treated with nicotinamide and trichostatin A, inhibitors
of class III and class I and II histone deacetylases, respectively. We
found that Tat association with BAF180 increased in the presence
of p300 as shown by co-immunoprecipitation of BAF180 with Tat
(Figure 4B). The same treatment markedly increased Tat
acetylation (Figure 4B). Importantly, the Tat(K50R/K51R)
mutant did not display increased affinity for BAF180 in response
to p300 (Figure 4B). Mutation of Tat residues Lys
50 and Lys
51 to
arginine decreased Tat acetylation significantly, but not complete-
ly, consistent with the existence of other Tat acetylation sites [53].
These results support a model in which p300 acetylated Tat
specifically recruits the PBAF complex to the HIV LTR.
Our data suggested that the distinct SWI/SNF complexes BAF
and PBAF might play temporally distinct roles in HIV
transcription: Tat-independent basal repression of promoter
activity by BAF and Tat-dependent activation of promoter activity
Figure 3. Reactivation of latent HIV mediated by knockdown of BAF subunits. (A) J-Lat A2 cells latently infected with LTR-Tat-IRES GFP virus
were transfected with either control siRNA or siRNAs targeting various SWI/SNF subunits as indicated. GFP expression was monitored by FACS at the
times indicated after transfection and is expressed as % GFP-positive cells. (B) J-Lat 11.1, clone of Jurkat cells containing a latent integrated full-length
HIV virus harboring GFP in place of Nef, was transfected with either control siRNA or siRNAs targeting various SWI/SNF subunits as indicated. GFP
expression was monitored by FACS at the times indicated after transfection and is expressed as % GFP-positive cells. Error bars represent the SEM of
five independent experiments. * p,0.05. (C) The BRG-1 complex remains intact following depletion of BAF or PBAF-specific subunits. BRG-1 was
immunoprecipitated from J-Lat A2 cells transfected with control siRNA or siRNA targeting BAF250 or BAF180, and its associated proteins were
examined by SDS-PAGE and Western blotting with antibodies against BRG-1 itself, the BAF or PBAF-specific subunits BAF250a, BAF180 and BAF200,
the core subunit INI-1 and GAPDH as control.
doi:10.1371/journal.pbio.1001206.g003
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knockdown of BAF250a and BAF180, unique to each complex, on
Tat-independent and Tat-dependent HIV transcription. Jurkat
1G5 cells contain an integrated LTR-luciferase reporter construct
and allow convenient monitoring of HIV promoter activity [54].
Cells were first transfected with siRNAs against either BAF180 or
BAF250a leading to their efficient depletion (Figure 4C). To probe
the effect of BAF/PBAF depletion on Tat-dependent LTR
transcription, we introduced Tat exogenously by re-transfecting
the cells with an expression vector for Tat or an empty control
vector. Nucleofection of siRNA or control vectors had no non-
specific effect on LTR-driven luciferase expression (Figure S4B).
As seen before (Figures 2 and 3), depletion of BAF250a and not
BAF180 resulted in an increase in basal promoter activity,
confirming the repressive role of BAF250a in Tat-independent
LTR-driven, luciferase expression in 1G5 cells (Figure 4D). In the
presence of Tat, depletion of BAF250a resulted in a significant
increase in Tat-mediated activation, suggesting a synergistic effect
between Tat expression and loss of the repressive BAF complex on
LTR activity. In contrast, depletion of BAF180 suppressed Tat-
dependent HIV promoter activity at both concentrations of Tat
tested (Figure 4D). CMV-driven Tat expression, driven by the
CMV promoter, was not affected by depletion of BAF180 or
BAF250a (Figure S4A). We also compared the effect of both wild
type and K50,51R mutant Tat in 1G5 cells containing or depleted
of BAF180 or BAF250a (Figure S4B). While depletion of BAF180
Figure 4. PBAF, recruited by K50K51 acetylated Tat, is a co-factor for Tat activation of the HIV promoter. (A) J-Lat A2 cells containing an
integrated LTR-Tat-FLAG-GFP were stimulated with PMA to induce expression of Tat-FLAG. Tat was immunoprecipitated from untreated or PMA-
stimulated cell lysates and its associated proteins were examined by SDS-PAGE and Western blotting with antibodies against the BAF- or PBAF-
specific subunits BAF250a and BAF180, and protein kinase D-1 and 14-3-3 as controls. (B) Tat co-immunoprecipitation with BAF180 is modulated by
Tat acetylation. Tat (wild-type or K50R/L51R) was immunoprecipitated using anti-FLAG antibody and analyzed by Western blotting using antibody
specific for BAF180. Tat acetylation levels were assessed using an anti-acetyl lysine antibody. All proteins were expressed at similar levels under the
different experimental conditions as shown by the Inputs. (C) 1G5 Jurkat cells containing integrated LTR-Luciferase (LTR-Luc) were nucleofected with
siRNAs against BAF180, BAF250, or with a control siRNA pool. Expression of BAF180, BAF250, and b-actin was analyzed by Western blotting after
depletion of either BAF180 or BAF250. (D) Transactivation of the HIV promoter by Tat is reduced in the absence of BAF180. 48 h after siRNA depletion
of BAF180 or BAF250, cells were re-transfected with either a control or Tat-expression vector (CMV-driven), and luciferase assay performed after 24 h.
Error bars represent the SEM of three independent experiments. * p,0.05. (D).
doi:10.1371/journal.pbio.1001206.g004
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significant suppressive effect on LTR activation by K50,51R
mutant Tat, supporting the notion that acetylated Tat recruits
PBAF to facilitate LTR activation. Altogether, these results
indicate that PBAF is specifically required for optimal Tat-
mediated transactivation of the HIV promoter.
Direct Binding of Distinct SWI/SNF Complexes to the HIV
Promoter Before and After Transcriptional Activation
Our results suggested that distinct subunits of the SWI/SNF
complexes are recruited to the HIV promoter in the absence and
presence of Tat. We used a combinatorial approach based on
formaldehyde crosslinking to determine the nucleosome density
and DNA accessibility at the LTR, and to demonstrate direct
interaction of SWI/SNF subunits with the HIV promoter
(Figure 5A). Chromatin from J-Lat 11.1, containing a latent
integrated full-length HIV virus (Figure 5) [46] or J-Lat A2 (Figure
S5), was prepared from cells at 0, 1, and 12 h after addition of
PMA to culture supernatants. Following formaldehyde cross-
linking, we fragmented chromatin by sonication, because it allows
the isolation of both nucleosome-bound DNA and nucleosome-
free DNA. To be able to distinguish between the nuc-0, DHS1,
nuc-1, and nuc-2 regions within the LTR by qPCR, we sonicated
the chromatin extensively to obtain small fragments of approxi-
mately 100–250 base pairs in size. To determine nucleosome
occupancy, we performed chromatin immunoprecipitation exper-
iments (ChIPs) using antibodies against histones H2B and H3
(Figure 5A and 5B). To independently map regions within the
HIV LTR that are depleted of nucleosomes, we used FAIRE
(Formaldehyde Assisted Isolation of Regulatory Elements)
(Figure 5A and 5C). FAIRE relies on a phenol-chloroform
extraction to isolate ‘‘nucleosome-free’’ DNA fragments that are
not cross-linked to histones, and thus provides a complementary
approach independent of antibodies, to examine chromatin
structure. To examine recruitment of SWI/SNF complexes to
the LTR, we subjected the sonicated chromatin to immunopre-
cipitation with BRG1, the BAF-specific BAF250a, and the PBAF-
specific BAF200 and BAF180 antibodies (Figure 5A and 5D). The
immunoprecipitated or phenol:chloroform extracted DNA was
analyzed by qPCR with primer pairs specific for the nuc-0, DHS1,
and nuc-1 regions of the HIV promoter (Figure 5A).
As shown in Figure 5C, PMA stimulation caused a dramatic
increase in DNA accessibility, observed over the positioned
repressive nuc-1 and encompassing nuc-0, DHS1, and nuc-2
albeit to a lesser extent. This observed increase in DNA
accessibility in response to PMA stimulation is accompanied by
a loss of histones bound to nuc-1 as determined by H2B and H3
ChIPs (Figure 5B). The ChIP results using antibodies directed
against either histone H3 or H2B correlated well with each other.
In agreement with the functional data discussed above and the
proposed repressive role of BAF on the HIV promoter, we
detected the BAF-specific subunit BAF250 and BRG1 bound to
the HIV promoter nuc-1 under basal conditions. A remarkable
switch in specific SWI/SNF subunits occurred in response to
PMA: the BAF-specific subunit BAF250 was lost from the HIV
promoter, while the PBAF-specific subunits, BAF180 and
BAF200, were recruited during the transcriptional activation of
the HIV promoter (Figure 5D). Compared to the control locus,
BRG1 was enriched on the HIV promoter in its repressed state
and slightly enriched in response to PMA stimulation. Thus, the
PBAF complex is absent from the HIV promoter under basal
conditions but recruited to the HIV promoter in response to PMA
stimulation, while BAF is directly associated with the HIV LTR
and required to maintain repression of the HIV promoter in the
absence of Tat.
BAF Is Essential for Positioning the Repressive nuc-1 of
HIV LTR
We next investigated the mechanism by which the BAF
complex represses HIV LTR activity. One intriguing possibility
was that nuc-1 positioning downstream of the transcription start
site might be an active process driven in part by BAF activity, ATP
hydrolysis. Our observation that nuc-1 becomes remodeled upon
ATP depletion (Figure S1) was consistent with this model. First we
examined the propensity for nucleosome formation of the DNA
sequence encompassing the first 1,800 base pairs of the HIV LTR
including the positioned nucleosomes nuc-0, nuc-1, nuc-2, and the
DNase hypersensitive sites (DHS1 and DHS2) in between
(Figure 6A). We determined histone binding affinity score
(nucleosome score) as the log likelihood ratio for the given region
to be a nucleosome versus a linker using NuPoP software tool [55].
Similar results were obtained with an alternative algorithm (Figure
S6A) [56,57]. The mean value for histone affinity score as shown
by the blue line and standard deviation shown in red are indicated
as reference to the known preferred genomic sites of HIV
integration [58]. Comparison of the predicted affinities to the
known in vivo positioning of nucleosomes within the HIV LTR
[5,6] demonstrated a remarkable opposite correlation (Figure 6A).
The region with the highest predicted propensity for nucleosome
formation encompasses the DHS1, the nucleosome-free region
found between the positioned nucleosomes nuc-0 and nuc-1.
Conversely, sequences encompassing nuc0 and nuc-1 have a lower
nucleosome score than the DHS1. The positioned nuc-2 and
DHS2 separating it from nuc-1 also appear to be the mirror image
of the nucleosome score predicted by their DNA sequences
(Figure 6A). The negative correlation between predicted and
actual nucleosome positioning in the HIV LTR together with the
presence and functional requirement of BAF on nuc-1 in the
repressed state suggested that BAF may counteract DNA sequence
effects to place the repressive nuc-1 in a thermodynamically sub-
optimal position.
We next sought to probe the role of BAF in nucleosome
positioning within the LTR using a siRNA approach to selectively
deplete BAF and PBAF subunits. To examine the impact of
depletion of BAF on local chromatin structure at the HIV LTR,
we first performed FAIRE experiments (Figure 6B and S6B).
Using FAIRE we assessed changes in DNA accessibility at the
HIV LTR following depletion of BAF and PBAF subunits
(Figure 6B). Strikingly, there was a sharp peak in DNA accessibility
at nuc-1 following loss of BAF250 and BRG1, accompanied by a
decrease in DNA accessibility over DHS1 (Figure 6B and S6B). In
contrast, knock-down of BAF180 or BAF200 had no significant
effect on DNA accessibility at the HIV LTR (Figure 6B and S6B).
We next examined nucleosome density by ChIP-qPCR using
antibodies specific for H2B and H3 combined with RNAi-
mediated protein depletion. Complementing the FAIRE data,
depletion of BAF250 and BRG1, but not BAF200 or BAF180,
caused a strong loss of histone H2B and H3 at nuc-1, which is
concomitant with increased DNA accessibility at this position
(Figure 6C and S6C). Interestingly, loss of histone density at nuc-1
was accompanied by an increase in histone density within the
DHS1 region (Figure 6C and S6C).
To examine if knock-down of individual subunits affects
recruitment of the complexes to the LTR, we performed ChIPs
to monitor BRG-1 enrichment at the LTR in BAF180 or BAF250-
depleted J-Lat 11.1 cells in the latent versus PMA stimulated states
(Figure 6D). We found that depletion of BAF250 abrogated
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PLoS Biology | www.plosbiology.org 8 November 2011 | Volume 9 | Issue 11 | e1001206Figure 5. Direct binding of distinct SWI/SNF complexes to the HIV promoter before and after transcriptional activation. (A) Schematic
representation of strategy to explore nucleosome position changes and enrichment of SWI/SNF at the HIV LTR in its repressed state and after PMA
stimulation. J-Lat 11.1 cells at 0, 1, and 12 h after PMA addition were crosslinked and sonicated to yield fragments of approximately 150 bp. DNA
accessibility was monitored by FAIRE while nucleosome occupancy was determined by histone H3 and H2B ChIPs. To determine enrichment of SWI/
SNF complexes, we performed ChIPs with antibodies specific for BAF250, BAF180, BAF200, and BRG1. (B) PMA stimulation causes a reduction in
histone density over HIV nuc-1 as determined by H3 and H2B ChIPs. Histone ChIPs are presented as percent immunoprecipitated DNA over input. (C)
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effect on recruitment of PBAF to nuc-1 in response to PMA
stimulation. Vice versa, BAF180 depletion abrogated PMA
dependent recruitment of the BRG-1 complex to nuc-1, but had
no effect on the enrichment of BAF at the LTR nuc-1 in the latent
state (Figure 6D). Thus, while BAF- and PBAF-specific factors
appear to be targeting subunits required for complex recruitment
to the LTR, they do not affect the recruitment of the other
functionally distinct complex to the LTR. Together our data
indicate that while PBAF is recruited by Tat to the HIV LTR and
required for Tat-mediated activation, the BAF complex is essential
for repression of basal LTR activity by countering histone-DNA
sequence preferences at the LTR and positioning the repressive
nuc-1 over less optimal sequences immediately downstream of the
transcription start site.
High Resolution Nucleosomal Mapping Reveals a
Dramatically Altered LTR Chromatin Structure After
Depletion of BAF250
Our data thus far demonstrated a critical role for the BAF250a
containing BAF chromatin remodeling complex in actively
maintaining a repressive nucleosomal structure at the HIV LTR.
To obtain a higher resolution picture of the dynamic changes in
LTR nucleosomal structure in the presence or absence of BAF250,
we performed high resolution MNase nucleosomal mapping, as
previously described [59,60]. We made slight modifications to this
protocol to be able to reproducibly visualize in vivo changes in the
LTR chromatin structure in the lower numbers of cells obtainable
after depletion of BAF250 by siRNA nucelofection. After
formaldehyde cross-linking, the isolated chromatin was divided
into undigested and MNase digested samples. Digested and
undigested DNA was then probed with 20 separate overlapping
primer sets, amplifying approximately 100 bp regions along the
HIV LTR (Figure 7A and Table S1). MNase cleaves nucleosome-
free and linker DNA connecting two nucleosomes, while DNA
within nucleosomes is at least partially protected and resistant to
digestion. Therefore, the amount of DNA remaining between two
primers after MNase digestion, which determines the ability of a
primer pair to amplify that region by real-time qPCR, can be used
to show the amount of digestion in a particular amplicon at the
HIV LTR. We calculated the relative ratio of the amount of
digested DNA to the undigested control for each overlapping
primer pair scanning the length of the HIV LTR (Figure 7A and
7B).
We examined first the LTR nucleosomal profile in J-lat 11.1
cells which were either unstimulated or treated with PMA for 1 or
12 h (Figure 7B red line). As shown previously [5–7], we find that
under unstimulated conditions, the HIV LTR contains two
distinct chromatin regions: a nucleosome positioned immediately
after the TSS (Nuc-1), and a second nucleosome (Nuc-0) at the 59
end of the LTR. 39 to the LTR, there is another strictly positioned
nucleosome (Nuc-2) as well as an intervening MNase hypersen-
sitive DNA region between the positioned Nuc-1 and Nuc-2.
Surprisingly, we found that DHS1 (nucleotides 200–452) connect-
ing Nuc-0 and Nuc-1 was not devoid of nucleosomes, but rather
contained poorly positioned nucleosomes as determined by partial
protection from MNase digestion (Figure 7B and 7C). This area,
previously demonstrated to be hypersensitive to nuclease digestion,
contains consensus binding sites for a range of host cell
transcription factors critical for LTR activity. PMA stimulation
at 1 h caused a striking decrease in DNA protection between the
positioned Nuc-0 and Nuc-2, indicating a loss of nucleosomes
within this region including the positioned Nuc-1 (Figure 7B, light
green line). At 12 h of PMA stimulation, a more significant and
broader loss of nucleosomal DNA protection occurred down-
stream of the positioned Nuc-0, which now included the
positioned Nuc-2 (Figure 7B, dark green line).
We next examined what effect depletion of BAF250a has on the
observed high resolution LTR nucleosomal structure. We depleted
BAF250 from J-Lat 11.1 cells using siRNA transfection and
compared the resulting LTR nucleosomal profile to that of cells
transfected with control siRNA (Figure 7D). As expected,
nucleofection of cells with control siRNA had no effect on the
LTR nucleosomal structure (Figure 7D, red and brown lines).
However, siRNA depletion of BAF250 resulted in a dramatically
altered LTR chromatin structure (Figure 7D, blue line).
Confirming our results from FAIRE experiments, depletion of
BAF250 coincided with a loss of the strictly positioned Nuc-1.
Interestingly, the sequences within the previously described DHS1
(between Nuc-0 and Nuc-1) and DHS2 (between Nuc1 and Nuc-2)
showed significantly more resistance to MNase digestion in the
BAF250-depleted samples. Thus, the nucleosomal landscape of
BAF250a-depleted J-Lat cells more closely resembles the predicted
nucleosome positioning within the LTR (Figure 6A), which is
determined by intrinsic histone-DNA sequence preferences. Thus,
confirming and extending our data obtained from FAIRE and
histone ChIP experiments (Figures 6 and S6), the observed
changes in the high resolution MNase chromatin profile of the
LTR in response to BAF250a depletion demonstrates a loss of
histones within Nuc-1 concomitant with an increase in histone
density over the DHS1.
Depletion of BAF Decreases the Incidence of Latent HIV
Infections in Jurkat and SupT1 Cells
The de-repression of latent infections observed in J-LatA2 and
J-Lat 11.1 cells in response to depletion of the BAF complex
subunits BAF250, INI-1, and BRG1 indicated that the BAF
complex is necessary to maintain silencing at the LTR during a
latent infection (Figure 3). Since depletion of BAF resulted in the
loss of the positioned repressive nuc-1 (Figure 6), we wondered
whether BAF contributes to the establishment of latent HIV
infections by positioning nuc-1 and repressing basal HIV
transcription. We therefore tested whether depletion of BAF
would decrease the establishment of latent infections. We used
siRNAs to deplete BAF250, or the core subunits BRG1 or INI-1,
or the PBAF-specific subunits BAF200 and BAF180 from Jurkat
cells (Figure 8A). In parallel we examined the effect of BAF/PBAF
depletion in latency establishment in another CD4+T cell line,
SupT1 cells (Figure S7). Using a strategy we and others described
previously [46,61], we then compared the percentage of latent
PMA stimulation is accompanied by an increase in DNA accessibility over the positioned nuc-1 of the HIV LTR. FAIRE results are presented as fold
change respective to the unstimulated value (normalized to 1) for each primer pair. (D) BAF250a-specific BAF complex directly binds to nuc-1 in its
repressed state, while BAF180 and BAF200-specific PBAF is recruited to nuc-1 upon PMA stimulation. SWI/SNF subunit ChIPs are presented as percent
immunoprecipitated DNA over input. Immunoprecipitated DNA from ChIPs and phenol:chloroform extracted DNA from FAIRE were analyzed by qPCR
using primer pairs specific for the HIV LTR nuc-0, DHS1, nuc-1, and nuc-2 regions, and control region amplifying upstream of the Axin2 gene. For all
ChIP and FAIRE experiments, error bars represent the SEM of at least three independent experiments. * p,0.05, ** p,0.01. We depict results for J-Lat
11.1. Similar results were obtained for J-Lat A2 (Figure S5).
doi:10.1371/journal.pbio.1001206.g005
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PLoS Biology | www.plosbiology.org 10 November 2011 | Volume 9 | Issue 11 | e1001206Figure 6. BAF represses HIV transcription by positioning nuc-1 of the HIV LTR. (A) Location of the strictly positioned nucleosomes
correlates negatively with the predicted histone binding affinity score (nucleosome score) of the DNA sequence encompassing the HIV LTR. Predicted
nucleosome affinity for HIV nucleotide sequence 1–1800 was determined using the algorithm described [55]. Similar results were obtained with an
alternative algorithm described (Figure S6) [56,57]. Means and standard deviations for nucleosome score at insertion sites are indicated by blue
(mean) and red lines (mean 6 SD) and give reference to known genomic sites of HIV integration [58]. (B) Depletion BAF250 and BRG1 results in a peak
in DNA accessibility over positioned nuc-1 and decreased accessibility over DHS1 of the HIV LTR. J-Lat 11.1 cells were nucleofected with either
nontargeting siRNA or siRNAs targeting individual SWI/SNF subunits as indicated and subjected to FAIRE. FAIRE results are presented as fold change
respective to value obtained for control siRNA transfected cells (normalized to 1) for each primer pair. (C) Depletion of BAF results in a reduction in
histone density over the positioned LTR nuc-1 as determined by H3 and H2B ChIPs. (D) BAF180 and BAF250 are distinctly required for targeting of the
BRG1 complex to the activated and silenced LTR nuc-1, respectively. Depletion of BAF250 abrogates targeting of the repressive BRG-1 complex while
BAF180 depletion interferes with recruitment of BRG1 to nuc-1 in response to PMA stimulation. J-Lat 11.1 cells were nucleofected with either
nontargeting siRNA or siRNAs targeting BAF250 or BAF180 as indicated. Depleted cells were then subjected to ChIPs using an antibody specific for
BRG1. BRG1 ChIPs were analyzed by qPCR using primer pairs specific for the LTR nuc-1 and control region amplifying upstream of the Axin2 gene and
are presented as percent immunoprecipitated DNA over Input. For all ChIP and FAIRE experiments, error bars represent the SEM of at least three
independent experiments. * p,0.05, ** p,0.01. We depict results for J-Lat 11.1. Similar results were obtained for J-Lat A2 (Figure S6).
doi:10.1371/journal.pbio.1001206.g006
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PLoS Biology | www.plosbiology.org 11 November 2011 | Volume 9 | Issue 11 | e1001206Figure 7. BAF250 depletion induces change in chromatin structure at the HIV LTR as detected by High Resolution MNase
nucleosomal mapping. (A) Diagram showing the PCR amplicons used at the HIV LTR covering nucleotides 40–902 corresponding to Nuc0, DHS1,
Nuc-1, DHS2, and Nuc-2. PCR products are 100610 bp in size and are spaced approximately 30 bp apart. (B) Change in chromatin structure of the HIV
LTR in J-Lat 11.1 cells upon PMA stimulation. The chromatin profile of the HIV LTR was determined at 0 (red line), 1 h (light green line), and 12 h (dark
green line) post-PMA stimulation by normalizing the amount of the MNase digested PCR product to that of the undigested product using the DC(t)
method (y-axis), which is plotted against the midpoint of the corresponding PCR amplicon (x-axis). The x-axis represents base pair units with 0 as the
start of LTR Nuc-0. Error bars represent the average of three independent experiments. (C) A loosely positioned nucleosome between the positioned
Nuc-0 and nuc-1 is indicated in pink. (D) Depletion of BAF250 induces restructuring of the HIV LTR chromatin profile. The chromatin profile of the HIV
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PBAF subunits (Figures 8B and S7A). Briefly, we infected Jurkat or
SupT1 cells at low multiplicity of infection with an HIV-1-derived
virus containing a GFP reporter, LTR-Tat-IRES-GFP. Percent
productive infections were scored as percent GFP positive cells
72 h after infection with virus (Figures 8B, 8C, S7A and S7B).
Using Flow Cytometry (FACS) we sorted the GFP negative
population, which presumably contained uninfected as well as
latently infected cells. Treatment of the GFP negative population
with PMA led to activation and GFP expression of the latently
infected population, which was analyzed and quantitated by FACS
(Figures 8B, 8D, S7A and S7C). As shown in Figures 8C and S7B,
the percentage of productive infections was slightly decreased in
the absence of BAF/PBAF subunits. However, depletion of the
core subunits INI-1 or BRG1 or the BAF-specific subunit BAF250
resulted in a significant, greater than 50% lower incidence of latent
infections in both Jurkat and SupT1 cells, while depletion of
PBAF-specific subunits had no significant effect on latency
establishment (Figures 8D and S7C). We also tested whether
similar to BAF, depletion of CHD3 also decreases the incidence of
latent infections (Figure S8). Using siRNAs we depleted CHD3,
BAF250, and BRG-1 either individually or simultaneously in both
Jurkat and SupT1 cells (Figure S8). Similar to BAF250 and BRG-1
depletion, depletion of CHD3 resulted in decreased incidence of
latent infections. However, we found no synergistic effect on
latency establishment when both BAF250 and CHD3 or BRG1
and CHD3 were simultaneously depleted by siRNA transfection.
These results suggest that the BAF complex contributes to the
establishment of latent infections and points to the ATP-dependent
enzyme BRG1 as a putative therapeutic target to deplete the latent
HIV-infected reservoir in infected patients.
Discussion
Our results suggest a novel model for the regulation of HIV
transcription and the role of the SWI/SNF chromatin-remodeling
complex (Figure 9). We find that, on the HIV LTR, active
chromatin remodeling is required for the generation of a
chromatin conformation that is repressive to transcription; the
BAF complex strictly positions nuc-1. Thus, in the absence of Tat,
BAF is bound to the HIV promoter where it represses
transcription by counteracting intrinsic nucleosome-DNA se-
quence preferences and positioning nuc-1 in a less energetically
favorable position immediately downstream of the TSS. Upon
activation, BAF is removed from the LTR, allowing the formation
of nucleosomes according to their intrinsic histone-DNA sequence
preferences. Upon expression, Tat first recruits acetyltransferases
resulting in the acetylation of promoter histones as well as Tat itself
[62–66]. Intriguingly, another SWI/SNF complex, PBAF, specif-
ically interacts with acetylated Tat and is recruited to the HIV
promoter by Tat in vivo. Thus, the biochemically distinct
chromatin-remodeling complexes BAF and PBAF display func-
tional specificity on the HIV promoter, one repressive and the
other participating in the transcriptional activation of the HIV
promoter by Tat. This model presents a considerably more
complex picture of the role of SWI/SNF proteins in the
transcriptional regulation of HIV expression than had previously
been anticipated.
The involvement of the BAF complex in repressing basal HIV
transcription raises a number of novel questions. Intriguingly,
HIV-1 integrase interacts with the SWI/SNF protein INI-1 in
vitro and in vivo [41]. During HIV infection, incoming retroviral
pre-integration complexes trigger the cytoplasmic export of the
SWI/SNF component INI1 and of the nuclear body constituent
PML [50]. The HIV genome associates with these proteins before
nuclear migration. In the presence of arsenic, PML is sequestered
in the nucleus and the INI-1/preintegration complex interaction is
disrupted [50]. Under these conditions, the efficiency of HIV-
mediated transduction is markedly increased. This observation
could be explained in part by our observations that the BAF
complex represses basal HIV transcription by positioning the
repressive nuc-1.
Why would the HIV virus position a repressive nucleosome
immediately downstream of its transcriptional start site? An
attractive possibility is that BAF may remove or pull the
thermodynamically favored nucleosome away from the promoter
(DHS1) to allow for binding of host cell transcription factors whose
binding sites are present within the DHS1. In particular, the
NFKB and Sp1 consensus sites within the DHS1 have been shown
to be critical for basal HIV LTR promoter activity [67]. In this
context, positioning of nuc-1 by BAF downstream of the TSS
would make consensus sites within the DHS1 accessible for
binding by sequence-specific transcription factors, and allow for
the assembly of the initiation complex. Surprisingly, our high-
resolution MNase nucleosomal mapping of the LTR demonstrated
that DHS1 is not devoid of nucleosomes as previously implied.
The DNA within this region displayed partial protection against
MNase digestion, indicating the presence of loosely positioned
nucleosomes, which disappeared upon PMA stimulation. Interest-
ingly, a previous study by Workman and colleagues argued for the
presence of a nucleosome over the HIV promoter (DHS1) and the
formation of a ternary complex consisting of the transcription
factors, histones, and DNA [68]. It is important to note that in this
study the HIV promoter/DHS1 sequence was reconstituted into
mono-nucleosomes or placed within an array of positioned
nucleosomes in vitro and outside the context of the adjacent
nuc-0 and nuc-1 sequences [68]. Our modeling data, depicting the
high predicted affinity (nucelosome score) of the DHS1 DNA
sequence (Figure 6A), are in agreement with these observations
implying the presence of a nucleosome over the DHS1 region in
vitro.
Our high-resolution MNase nucleosomal mapping data provide
a detailed picture of the dynamic nucleosomal landscape of the
HIV LTR, comparing the latent, PMA activated, and BAF-
depleted de-repressed LTR states. Loss of BAF250a caused a
dramatic re-positioning of the nucleosomes according to their
intrinsic DNA-histone sequence preference; DNA encompassing
nuc-1 became hypersensitive and susceptible to digestion by
MNase while the DHS sites were rendered less accessible and
protected from MNase, more closely resembling the predicted
LTR nucleosomal structure (Figure 6A). These results support a
nucleosome repositioning model upon BAF250a depletion, which
contrasts with the observed eviction of nucleosomes downstream of
the positioned Nuc-0, which occurs after PMA stimulation.
An important question remaining to be resolved is how BAF is
recruited to the LTR to position nuc-1. SWI/SNF complexes have
been shown to function gene-specifically, recruited by sequence-
specific transcription factors to regulatory regions of target genes.
The HIV LTR contains many binding sites for multiple sequence-
specific host transcription factors, including SP1, NFkb, YY-1,
LTR was determined in J-Lat 11.1 cells nucleofected with either control siRNA (brown line) or siRNA targeting BAF250 (blue line). The chromatin
profile of untransfected cells are also provided for comparison (red line). Error bars represent the SEM of three independent experiments.
doi:10.1371/journal.pbio.1001206.g007
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BAF by a repressive sequence-specific transcription factor bound
to nuc-1. A number of transcriptional repressors contain binding
sites within the region occupied by nuc-1, including LSF-1 and
YY-1 [69]. Indeed, the transcriptional repressor YY-1 was bound
to the HIV promoter under basal conditions and was displaced in
response to Tat expression [38]. Thus, YY-1 is a candidate
transcription factor, which may recruit BAF to the HIV LTR to
Figure 8. BAF promotes the establishment of latent HIV infections. (A) Western blot analysis demonstrates depletion of BAF/PBAF subunits
as indicated 96 h after siRNA transfection. (B) Schematic representation of protocol for comparison of productive and latent infections in Jurkat cells
containing or depleted of remodeling complex subunits. Jurkat cells were first nucleofected with control siRNA or siRNA targeting individual SWI/SNF
subunits as indicated. After 48 h, cells were infected with retroviral particles containing the vector LTR-Tat-IRES-GFP. The percentage of productive
infections (GFP-positive cells obtained after infection (12.2%) (left panel)), FACS-sorted GFP-negative cells (middle panel), or percent latent infections
(GFP-positive cells obtained after PMA treatment of sorted GFP-negative cells (0.64%) (right panel)) are shown for Jurkat cells nucleofected with
control siRNA. (C) Depletion of BAF/PBAF subunits as indicated does not significantly affect the percentage of productive HIV infections. (D) Depletion
of the core SWI/SNF subunits BRG1 and INI-1 and the BAF-specific subunit BAF250 significantly decreases the incidence of latent HIV infections (the
percent GFP positive cells obtained after PMA stimulation of GFP negative cell population) while depletion of PBAF-specific subunits BAF200 or
BAF180 had no significant effect on latency establishment.
doi:10.1371/journal.pbio.1001206.g008
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pleiohomeotic (PHO), the Drosophila homologue of YY-1, has
been shown to directly recruit the SWI/SNF complex to target
genes [70]. Conversely, the BAF complex, which itself may be
recruited by another sequence-specific transcription factor, may
allow for YY-1 binding, leading to de-acetylation of histones at the
LTR, and the repression of HIV transcription under basal
conditions.
Our results indicate that BAF-remodeling activity is necessary to
position nuc-1 downstream of the transcriptional start site. The
Figure 9. Model for SWI/SNF regulation of HIV LTR transcription. BAF uses energy from ATP hydrolysis to actively counteract intrinsic
histone-DNA sequence preferences within HIV LTR. (A–B) BAF pulls/pushes a preferred nucleosome over DHS1 onto DNA sequences less favorable for
nucleosome formation immediately downstream of the transcription start site (TSS), leading to positioning of nuc-1 and transcriptional repression. (C)
Upon activation, BAF dissociates from the LTR resulting in re-positioning of the nucleosomes to thermodynamically more favorable positions leading
to de-repression of HIV transcription. (D) Upon Tat expression, p300, recruited to the LTR, acetylates Tat. (E) p300-acetylated Tat then selectively
recruits the PBAF complex, which uses energy from ATP hydrolysis to actively re-position nucleosomes formed downstream of TSS enabling efficient
transcription elongation.
doi:10.1371/journal.pbio.1001206.g009
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consistent with this model and, within the limitations of this
experiment, suggests that nuc-1 positioning downstream of the
TSS is an active process driven in part by ATP and BAF activity.
Complementing the ChIPs, we used FAIRE to assess changes in
DNA accessibility within nuc-0, DHS1, and nuc-1 regions of the
HIV LTR in response to specific depletion of BAF or PBAF. The
mapping of accessible DNA within the LTR by FAIRE negatively
correlated with histone H3 and H2B occupancy. Our data
indicate that the specific depletion of BAF causes nucleosome
repositioning in accordance with intrinsic histone-DNA sequence
preferences; in the absence of BAF, the DHS1 region, whose
sequence displays a higher propensity for nucleosome formation,
displays higher histone density and lower accessibility, while the
opposite profile is observed for the DNA sequence encompassing
nuc-1. These observations suggest that the energetic cost of
positioning the repressive nuc-1 downstream of the TSS is
provided and driven by ATP hydrolysis. BAF positions nuc-1 by
either pushing the nucleosome from its optimal sequence over
DHS1 or by pulling it onto sub-optimal sequences encompassing
nuc-1. Thus, the BAF complex counteracts and overrules the
DNA sequence effects and intrinsically favored nucleosome
position over the DHS1 region of the HIV LTR.
The dramatic increase in DNA accessibility over nuc-1
concomitant with de-repression of LTR activity observed upon
depletion of the BAF complex begs the following question: why is
recruitment of PBAF by Tat necessary to drive transcription at the
LTR? In such a context, the recruitment by Tat of an alternative
complex, PBAF, may be necessary for remodeling of the
nucleosomes, formed in the absence of BAF according to their
preferred DNA sequences, downstream of the TSS, leading to
efficient transcription elongation (Figure 9). Indeed, BRG1 was
recently shown to be recruited to and facilitate RNA Pol II to
overcome nucleosomal barriers during transcription elongation in
vivo [71].
The balance between activating and repressive cofactors at the
LTR is believed to determine the level of basal transcription from
the LTR in the immediate early, Tat-independent phase of HIV
transcription. The local availability of positive and negatively
acting cofactors at the LTR therefore determines the likelihood of
transcriptional silencing. Our data demonstrated a critical role for
BAF in positioning nuc-1 and maintaining HIV LTR silencing.
We found that depletion of BAF led to a de-repression of latent
HIV in the J-Lat system reflecting HIV latency. Despite the
effectiveness of modern HAART regimens, latent HIV-infected
cells persist in patients, providing the main impediment to cure
from HIV infection. Recently, the need for the development of
new strategies to treat HIV-infected patients has been discussed
[72], highlighting the necessity to deplete the latent HIV-infected
reservoirs. As the catalytic subunit of the BAF complex, the
enzyme BRG1 may present an attractive candidate for drug
targeting to purge the latent HIV-infected reservoir in the
treatment of HIV.
Materials and Methods
Cell Lines and Plasmids
We used the following cell lines: Jurkat clones D and E
(containing integrated LTR-GFP), J-Lat A2 (integrated latent
LTR-Tat-IRES GFP), J-Lat 11.1 (integrated latent full-length
HIV genome containing a mutation in the env gene and GFP in
place of the nef gene) [45,46], and Jurkat 1G5 cells containing
integrated LTR-Luciferase [54]. The HIV LTR-luciferase report-
er construct (pEV229), the CMV-driven expression vectors for
FLAG-tagged wild-type Tat (pEV280), FLAG-tagged mutant
Tat(K50R/K51R) (pEV538), and p300 have been described
[62]. Plasmids used to generate HIV-derived virus particles,
vesicular stomatitis virus envelope (VSVG), the NL4-3 packaging
vector (R8.91), and the retroviral vector LTR-Tat-IRES-EGFP
(pEV731), have been previously described [45].
Sodium Azide Treatment and Chromatin-Remodeling
Assay
Exponentially growing Jurkat cell line D or J-Lat A2 were
treated with increasing concentrations of sodium azide overnight.
Restriction enzyme accessibility with AflII was performed on
intact nuclei followed by Southern blotting as previously described
[45]. Briefly, cells were harvested by centrifugation and washed
with ice-cold PBS. The subsequent steps were performed on ice
with precooled buffers. Cells (10
7) were resuspended in 400 mlo f
buffer A (10 mM Tris, pH 7.4, 10 mM NaCl, 3 mM MgCl2,
0.3 M sucrose) and incubated on ice for 10 min. An equal volume
of buffer A/0.2% NP-40 was added, and cells were incubated for a
further 10 min. Nuclei were pelleted at 2406g for 10 min,
resuspended in 50 ml of buffer B (10 mM Tris, pH 7.9, 10 mM
MgCl2, 50 mM NaCl, 1 mM dithiothreitol, 100 mg/ml BSA,
0.1 mM phenylmethylsulfonyl fluoride), and digested for 20 min
with AflII (0.5 U/ml) at 37uC. Digestion reactions were placed on
ice, and genomic DNA was purified with DNeasy Tissue kit
(Qiagen). The same amounts of DNA from each sample were
digested to completion with NcoI. The extent of AflII cleavage was
detected by southern blotting. Hybridization was performed with a
32P-labeled PCR probe corresponding to a fragment internal to
the 59LTR generated from pRRL GFP vector by PCR. Primer
sequences are provided in Table S1.
Antibodies, Coimmunoprecipitation, and Western Blot
Analysis
Anti-BRM, anti-SMARCB1 and anti-SMARCA5/hISWI (Ab-
cam), anti-SMARCA4/BRG1, anti-ARID1a/BAF250a and anti-
14-3-3 (Santa Cruz Biotechnology), anti-BAF200 (kind gift from
C.P. Verrijzer), and anti-BAF180 (abcam and kind gift from W.
Wang and D. Murray) were used in Western blot and
immunoprecipitation experiments. For immunoprecipitations, Jlat
A2 cells were treated with 10 nM phorbal 12 myristate 13-acetate
(PMA) for 12–16 h to produce Tat-FLAG. Cells were lysed in IP
buffer (25 mM HEPES, pH 7.9, 150 mM KCl, 1 mM EDTA,
5 mM MgCl2, 5% glycerol, 1% NP40, 0.5 mM dithiothreitol,
1 uM TSA, 1 mM nicotinamide, and a protease inhibitor (PI)
cocktail (Sigma)) for 20 min on ice and passed through a 26-gauge
needle twice. Lysates were centrifuged, and 2 mg of whole-cell
protein lysate was incubated with 20 ul M2 agarose beads (Sigma)
in immunoprecipitation (IP) buffer overnight at 4uC on a rotator.
After five washes with IP buffer, beads were resuspended in SDS
loading buffer, and co-immunoprecipitated proteins were separat-
ed on an SDS-PAGE gel and identified by Western blotting. For
Tat immunoprecipitation in 293T cells, cells were transfected with
empty pcDNA3.1 or N-terminally FLAG-tagged wild-type or
mutant K50R/K51R Tat (pEV280 or pEV537) in presence or
absence of expression vector for p300; 36 h after transfection, cells
were stimulated with 1 mm TSA and 5 mm nicotinamide for 6 h,
harvested, and lysed in buffer (phosphate-buffered saline, 2 mm
EDTA, 1% Triton X-100, 0.5 mm dithiothreitol, 1 mm TSA,
5 mm nicotinamide and PI cocktail). 5 mg protein lysate was
incubated overnight with 40 ml M2-agarose beads at 4uCo na
rotator. Beads were washed extensively with lysis buffer,
resuspended in SDS loading buffer and co-immunoprecipitaed
Repressive HIV LTR Nucleosome Positioning by BAF
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antibodies.
Amaxa Nucleofection and siRNA Depletion
Nucleofection of Jurkat cells, SupT1 cells, and Jurkat cell clones
D, E, J-Lat A2, 11.1, and 1G5 cells was conducted as previously
described [38]. Cells were split to 3610
5 cells/ml 24 h before
Amaxa nucleofection. Five million cells were centrifuged at
1,000 rpm for 10 min at room temperature, resuspended in
100 ml of solution R, and nucleofected with 20 nM siRNA or 2 mg
of expression plasmid using program O28. Nucleofected cells were
resuspended in 500 ml of prewarmed, serum-free RPMI lacking
antibiotics and allowed to recover at 37uC in a 5% CO2 incubator
for 15 min. Prewarmed complete RPMI (4 ml) was then added to
the cells. Dharmacon siRNA control and on-target smartpools
targeting transcripts of the human SMARCB1, SMARCA4,
SMARCA2, SMARCA5, CHD3, INO80, PB1, ARID2, ARID1a,
and ARID1b genes were used to knockdown the expression of
respective genes in Jurkat and SupT1 cells, Jurkat clones D, E, J-
Lat A2, 11.1, and 1G5 cells. Protein levels were examined by
Western blot analysis 0, 2, 4, 6, 7, 8, 10, and 14 d after
nucleofection.
Flow Cytometry
Samples were analyzed on a FACS Calibur flow cytometer with
Cell Quest software (Becton Dickinson). The live population was
defined by forward versus side scatter profiles. Cells were further
gated by using forward scatter versus FL1 to differentiate between
GFP-positive and -negative cells. GFP expression in the J-Lat cell
lines was analyzed by FACS at 0, 2, 4, 6, 7, 8, 10, 12, and 14 d
after siRNA nucleofection.
Chromatin Immunoprecipitation, FAIRE, and Quantitative
PCR (qPCR)
J-Lat A2 and 11.1 cells were fixed by adding formaldehyde to a
final concentration of 1% for 10 min for histone IPs and FAIRE
and 30 min for BAF/PBAF subunit IPs at RT. The reaction was
quenched with 125 mM glycine, cells washed with buffer B (0.25%
Triton-X 100, 1 mM EDTA, 0.5 mM EGTA, 20 mM Hepes,
pH 7.6), buffer C (150 mM NaCl, 1 mM EDTA, 0.5 mM EGTA,
20 mM Hepes, pH 7.6), and resuspended in ChIP incubation
buffer (0.3% SDS, 1% Triton-X 100, 0.15 M NaCl, 1 mM
EDTA, 0.5 mM EGTA, 20 mM Hepes, pH 7.6). Chromatin was
sheared by sonication to an apparent length of ,200–400 bp
(corresponding to ,100–200 bp of free DNA) using a BioRuptor
sonicator (Cosmo Bio Co., Ltd) with 22 45-s pulses at maximum
setting. More than 20 million cells were used per IP, and 5 mgo f
the indicated antibody was incubated with the chromatin and
BSA-blocked protein G beads overnight at 4uC. IPs were washed
twice with each buffer 1 (0.1% SDS, 0.1% deoxycholate, 1%
Triton-X 100, 150 mM NaCl, 1 mM EDTA, 0.5 mM EGTA,
20 mM Hepes pH 7.6), buffer 2 (0.1% SDS, 0.1% deoxycholate,
1% Triton-X 100, 0.5 M NaCl, 1 mM EDTA, 0.5 mM EGTA,
20 mM Hepes pH 7.6), buffer 3 (250 mM LiCl, 0.5% deoxycho-
late, 0.5% NP-40, 1 mM EDTA, 0.5 mM EGTA, 20 mM Hepes,
pH 7.6), and buffer 4 (1 mM EDTA, 0.5 mM EGTA, 20 mM
Hepes, pH 7.6). Immunoprecipitated complexes were eluted in
elution buffer (1% SDS, 0.1 M NaHCO3) for 20 min at RT, and
decrosslinked overnight at 65uC in presence of 200 mM NaCl2.
DNA was phenol:chloroform extracted, chroloform:isoamylalco-
hol extracted, ethanol precipitated, and resuspended in 100 ml
H2O by shaking at 37uC. Input and immunoprecipitated DNA
(5 ml) were subjected to Sybergreen Q PCR cycles with specific
primers. For FAIRE, cells were subjected to formaldehyde
crosslinking for 10 min. 20 mg of cross-linked chromatin was
diluted 96 with buffer D (150 mM NaCl, 20 mM Tris-HCl
pH 8.1, 2 mM EDTA pH8.0, 1% Triton-X100 and PI cocktail)
and phenol-chloroform extracted. Isolated DNA was subjected to
Sybergreen Q PCR cycles with specific primers.
High- Resolution MNase Nucleosomal Mapping
High resolution MNase mapping protocol [59,60] of the HIV
LTR was slightly modified to be amenable to the lower cell
numbers obtainable after siRNA depletion of specific factors.
Briefly, cells were cross-linked according to the ChIP protocol
described above. After one wash in cold PBS, 1.5610
7 cross-
linked cells were resuspended in 1 ml hypotonic buffer A (300 mM
sucrose, 2 mM Mg acetate, 3 mM Cacl2, 10 mM Tris pH 8.0,
0.1% Triton X-100, 0.5 mM DTT), incubated on ice for 5 min,
and dounced 20 times with 2 ml dounce homogenizer (tight pestle,
Wheaton). Nuclei were collected by centrifuging at 4uC for 5 min
at 7206g. Pellets were resuspended in 1 ml buffer D (25%
glycerol, 5 mM Mg acetate, 50 mM Tris pH 8.0, 0.1 mM EDTA,
5 mM DTT) at 1.5610
7 nuclei/ml. Chromatin was collected by
centrifuging at 4uC for 5 min at 7206g. The pellets were
resuspended in 1 ml buffer MN (60 mM KCl, 15 mM NaCl,
15 mM Tris pH 7.4, 0.5 mM DTT, 0.25 mM sucrose, 1.0 mM
CaCl2) at 2.5610
7 nuclei/ml. The equivalent of 2.5610
6 nuclei
were used per MNase reaction. MNase (USB), diluted in buffer
MN, was added so that 0, 0.5, 5, 20, 50, and 500 total units were
used per 150 ul reaction and digested for 30 min at room
temperature. Reactions were stopped with the addition of EDTA
and SDS to final concentrations of 12.5 mM and 0.5%
respectively. After 4 hours of proteinase K digestion at 37uC,
each reaction was processed similar to ChIP samples from the
point of elution from the beads.
Real-Time qPCR Analysis
ChIP, FAIRE, and MNase digested samples were analyzed by
quantitative PCR in an iCycler iQ real-time PCR detection system
(BioRad) using iQ Sybergreen Supermix (BioRad). ChIP values
were normalized as a percentage of input. Sequences of qPCR
primer pairs used to amplify distinct regions within the HIV-1
LTR are provided in Table S1. For MNase digests a fold
difference was calculated using the DCT method between MNase
treated and untreated samples. All values used were collected from
the linear range of amplification.
Analysis of HIV LTR Sequence for Nucleosome Propensity
The NuPoP algorithm has been described [55]. An alternative
algorithm was also used to predict the nucleosome affinity for HIV
nucleotide sequence 1–1800 [56,57]. Estimates of the genomic
sites of HIV integration were derived from [58].
Latency Establishment Experiment
HIV-derived virus particles were generated as described [45].
Briefly, 293T cells were transfected with VSVG, the NL4-3
packaging vector, and the retroviral vector LTR-Tat-IRES-EGFP
(pEV731). Virus was harvested every 12 h starting at 24 h after
transfection. Jurkat or SupT1 cells containing or depleted of
BRG1, BAF250, BAF200, BAF180, INI-1, or CHD3, by siRNA
transfection, were infected with the LTR-Tat-IRES-EGFP virus at
low MOI such that less than 20% of cells were infected. 96 h after
infection, the GFP negative cell population harboring uninfected
as well as presumably latently infected cells were sorted (once or
twice depending on the purity of the GFP negative population) by
Repressive HIV LTR Nucleosome Positioning by BAF
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were then treated with PMA and analyzed by FACS after 24 h to
determine the percent GFP positive (latent) infections.
Supporting Information
Figure S1 ATP depletion results in nuc-1 remodeling and HIV
promoter activation. (A) Schematic representation of the restriction
sites and probe used to analyze the remodeling of nuc-1. Nuclei
isolated from cells treated either with PMA or sodium azide (NaN3)
were digested in vitro with AflII to probe for accessibility of the DNA
encompassing nuc-1. Genomic DNA was subsequently digested with
NcoI in vitro, and the DNA was analyzed by indirect-end labeling.
The NcoI genomic fragment (fragment B) and the double NcoI/AflII
digestion product (fragment A) are shown. (B) Indirect-end labeling
after PMA or NaN3 treatment and (C) corresponding increase in
GFP expression in Jurkat clone D containing an integrated LTR-
GFP virus. (D) Indirect-end labeling after NaN3 treatment and (E)
corresponding increase in GFP expression in J-Lat A2 containing an
integrated latent LTR-Tat-IRES-GFP virus. GFP, measured by flow
c y t o m e t r y ,i ss h o w na sm e a nf l u o r e s c e n c ei n t e n s i t y( M F I )( C )o r
increase in percent GFP positive cells (E) 16 h after treatment as
detailed above. The intensities of bands from three experiments were
quantitated using Odyssey software and used to compare fold
increase in ratio of bands A/B in each condition and plotted as mean
6 SEM. * p,0.05, ** p,0.01.
(PDF)
Figure S2 Stability of SWI/SNF complex component protein
levels after siRNA depletion of individual subunits. Jurkat cells
containing an integrated LTR-GFP virus (clone D) were
transfected with either control siRNA or siRNAs targeting various
SWI/SNF complex subunits as indicated. Western blot analysis
shows expression of SWI/SNF complex subunits in presence of
siRNA depletion of distinct subunits as indicated.
(PDF)
Figure S3 The BAF250a, but not BAF250b-containing BAF
complex, is specifically required for maintenance of repression of
latent HIV. (A) J-Lat A2 cells latently infected with LTR-Tat-
IRES GFP virus were nucleofected with either control siRNA or
siRNAs targeting BAF250a, BAF250b, and BRG-1 as indicated.
GFP mRNA expression was determined by RT-PCR at the times
indicated after transfection, was normalized to GAPDH, and is
presented as fold increase over untransfected control. (B) RT-PCR
analysis indicated stable depletion of ARID1B/BAF250b mRNA
up to 6 d after siRNA transfection. Error bars represent the SEM
of three independent experiments. * p,0.05, ** p,0.01.
(PDF)
Figure S4 BAF180-facilitated Tat activation of the LTR is
dependent on Tat residues K50,51. (A) CMV-driven luciferase
activity is not affected by the depletion of either BAF180 or
BAF250a. Jurkat cells were nucleofected with siRNAs against
BAF180, BAF250, or with a control siRNA pool. Forty-eight
hours after siRNA treatment, cells were transfected with a CMV-
luciferase vector. (B) Transactivation of the HIV promoter by
wild-type but not K50,51 mutant Tat is reduced in the absence of
BAF180. Jurkat cells containing integrated LTR-Luciferase (LTR-
Luc) were nucleofected with siRNAs against BAF180, BAF250, or
with a control siRNA pool. After 48 h, cells were re-transfected
with either a control, a CMV-driven wild-type Tat or K50,51R
mutant Tat-expression vector. Luciferase was measured after 24 h.
Error bars represent the SEM of three independent experiments. *
p,0.05.
(PDF)
Figure S5 Analysis of chromatin structure and direct binding of
distinct SWI/SNF complexes to the HIV promoter before and after
PMA stimulation in J-Lat A2. (A) PMA stimulation causes increase
in DNA accessibility over the LTR nuc-1. FAIRE results are
presented as fold change respective to unstimulated value for each
primer pair. (B) PMA stimulation is accompanied by reduction in
histone density over LTR nuc-1 as determined by H3 and H2B
ChIPs. Histone ChIP results are presented as fold change (histone/
mock IP) respective to unstimulated value for each primer pair. (C)
BAF directly binds to nuc-1 in its repressed state, while PBAF is
recruited to nuc-1 upon PMA stimulation. SWI/SNF subunit
ChIPs are presented as ratio of immunoprecipitated DNA over
input. Immunoprecipitated DNA from ChIPs and phenol:chloro-
form extracted DNA from FAIRE were analyzed by qPCR using
primer pairs specific for nuc-0, DHS1, and nuc-1 LTR regions. For
all ChIP and FAIRE experiments, error bars represent the SEM of
at least three independent experiments. * p,0.05, ** p,0.01.
(PDF)
Figure S6 BAF positions nuc-1 of HIV LTR. (A) Location of
strictly positioned nucleosomes correlate negatively with the
predicted histone binding affinity score (nucleosome score) of the
DNA sequence encompassing the HIV LTR. Similarity of the
predicted nucleosome affinity for HIV nucleotide sequence 1–
1800 determined using the algorithm described in (Xi et al., 2010
[55]) (shown in black) and an alternative algorithm described in
(Kaplan et al., 2009 [56]; Segal et al., 2006 [57]) (shown in red).
(B) Depletion of BAF250 and BRG1 results in a peak in DNA
accessibility over LTR nuc-1. J-Lat A2 cells were nucleofected
with either control nontargeting siRNA or siRNAs targeting
individual SWI/SNF subunits as indicated and subjected to
FAIRE after 72 h. FAIRE results are presented as fold change
respective to the value obtained for control siRNA transfected cells
given a value of 1 for each primer pair. (C) Depletion of BAF
results in reduced histone density over nuc-1 of HIV LTR as
determined by H3 and H2B ChIPs. Histone ChIP results are
presented as percent immunoprecipitated over Input. For all ChIP
and FAIRE experiments error bars represent the SEM of at least
three independent experiments. * p,0.05, ** p,0.01.
(PDF)
Figure S7 BAF promotes the establishment of latent HIV
infections in SupT1 cells. (A) Top panel: schematic representation
of protocol for comparison of productive and latent infections in
SupT1 cells containing or depleted of remodeling complex
subunits. SupT1 cells were first nucleofected with control siRNA
or siRNA targeting individual SWI/SNF subunits as indicated.
After 48 h, cells were infected with retroviral particles containing
the vector LTR-Tat-IRES-GFP. The percentage of productive
infections (GFP-positive cells obtained after infection (16.2%) (top
panel)), FACS-sorted GFP-negative cells (middle panel), or percent
latent infections (GFP-positive cells obtained after PMA treatment
of sorted GFP-negative cells (2.63%) (bottom panel)) are shown for
SupT1 cells nucleofected with control siRNA. (B) Depletion of
BAF/PBAF subunits as indicated does not significantly affect the
percentage of productive HIV infections. (C) Depletion of the core
SWI/SNF subunits BRG1 and INI-1 and the BAF-specific subunit
BAF250 significantly decreases the incidence of latent HIV
infections (the percent GFP positive cells obtained after PMA
stimulation of GFP negative cell population) while depletion of
PBAF-specific subunits BAF200 or BAF180 had no significant
effect on latency establishment. (D) Western blot analysis
demonstrates depletion of BAF/PBAF subunits as indicated 96 h
after siRNA transfection.
(PDF)
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establishment of latent HIV infections. Jurkat cells (A–C) or
SupT1 cells (D–F) were first nucleofected with control siRNA or
siRNA targeting BAF250, BRG1, CHD3, BAF250 together with
CHD3, or BRG1 together with CHD3. After 48 h, cells were
infected with retroviral particles containing the vector LTR-Tat-
IRES-GFP. The percentages of productive or latent infections
were determined as described in Figures 8 and S7. Depletion of
CHD3 and BAF subunits alone or together with CHD3 does not
significantly affect the percentage of productive HIV infections in
either Jurkat (A) or SupT1 (D) cells. Depletion of BAF subunits
BRG1 and BAF250 and the Mi2 catalytic subunit CHD3
significantly decreases the incidence of latent HIV infections.
However, simultaneous depletion of BAF and CHD3 does not
result in an additive decrease in latency establishment in Jurkat (B)
or SupT1 (E) cells. Western blotting analysis indicates depletion of
the indicated remodeling subunits in Jurkat (C) and SupT1 (F) cells
96 h post-siRNA transfection.
(PDF)
Table S1 Primer pairs used to analyze ChIP, FAIRE, and
MNase experiments by qPCR.
(PDF)
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